SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-10-002167
Filing Date
2010-01-15
Accepted
2010-01-15 10:54:32
Documents
18
Period of Report
2010-01-15

Document Format Files

Seq Description Document Type Size
1 v171490_6k.htm 6-K 926813
2 GRAPHIC graph1.jpg GRAPHIC 10622
3 GRAPHIC graph10.jpg GRAPHIC 22176
4 GRAPHIC graph11.jpg GRAPHIC 22711
5 GRAPHIC graph12.jpg GRAPHIC 67717
6 GRAPHIC graph13.jpg GRAPHIC 4890
7 GRAPHIC graph14.jpg GRAPHIC 4849
8 GRAPHIC graph15.jpg GRAPHIC 4800
9 GRAPHIC graph16.jpg GRAPHIC 127157
10 GRAPHIC graph2.jpg GRAPHIC 9485
11 GRAPHIC graph3.jpg GRAPHIC 23386
12 GRAPHIC graph4.jpg GRAPHIC 26079
13 GRAPHIC graph5.jpg GRAPHIC 45153
14 GRAPHIC graph6.jpg GRAPHIC 20876
15 GRAPHIC graph7.jpg GRAPHIC 20404
16 GRAPHIC graph8.jpg GRAPHIC 14678
17 GRAPHIC graph9.jpg GRAPHIC 22922
18 GRAPHIC logo1.jpg GRAPHIC 3966
  Complete submission text file 0001144204-10-002167.txt   1553110
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 10529222
SIC: 2834 Pharmaceutical Preparations